The use of ultra-short-acting opioids in paediatric anaesthesia the role of remifentanil

Clinical Pharmacokinetics

Volumn 44, Issue 8, 2005, Pages 787-796

  Davis, Peter J ^a   Cladis, Franklyn P ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; DESFLURANE; FENTANYL; ISOFLURANE; OPIATE DERIVATIVE; PIPERIDINE DERIVATIVE; PROPOFOL; REMIFENTANIL; SEVOFLURANE;

ADENOIDECTOMY; ANALGESIA; APNEA; BRADYCARDIA; CLINICAL TRIAL; DENTAL SURGERY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENCY; DRUG SENSITIVITY; ENDOTRACHEAL INTUBATION; HEMODYNAMICS; HUMAN; HYPOXEMIA; HYPOXIA; MEAN ARTERIAL PRESSURE; PEDIATRIC ANESTHESIA; POSTOPERATIVE NAUSEA; POSTOPERATIVE VOMITING; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RESPIRATORY TRACT DISEASE; REVIEW; SEIZURE; STRABISMUS SURGERY; TONSILLECTOMY;

ANALGESICS, OPIOID; ANESTHESIA, GENERAL; ANESTHETICS, INTRAVENOUS; BLOOD PRESSURE; CHILD; HEART RATE; HUMANS; NAUSEA; PIPERIDINES; RESPIRATORY INSUFFICIENCY; SEIZURES; VOMITING;

EID: 23744469392     PISSN: 03125963     EISSN: 03125963     Source Type: Journal    
DOI: 10.2165/00003088-200544080-00002     Document Type: Review

References (47)

1. Anand KJ, Hickey PR. Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery. N Engl J Med 1992; 326 (1): 1-9
2. Amin HM, Sopchak AM, Esposito BF, et al. Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil and alfentanil. J Pharmacol Exp Ther 1995; 274: 34-9
3. Davis PJ, Stiller RL, Wilson AS, et al. In vitro remifentanil metabolism: the effects of whole blood constituents and plasma butyrylcholinesterase. Anesth Analg 2002; 95: 1305-7
4. Hoke JF, Cunningham F, James MK, et al. Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR990291) and alfentanil in dogs. J Pharmacol Exp Ther 1997; 281: 226-32
5. Egan TD, Lemmens HJM, Fiset P, et al. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 1993; 79: 881-92
6. Egan TD, Minto CF, Hermann DJ, et al. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 1996; 84: 821-33
7. Glass PSA, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg 1999; 89: S7-14
8. Glass PSA, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg 1993; 77: 1031-40
9. Westmoreland CL, Hoke JF, Sebel PS, et al. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 1993; 79: 893-903
10. Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 1991; 74: 53-63
11. Kapila A, Glass PSA, Jacobs JR, et al. Measured contextsensitive half times of remifentanil and alfentanil. Anesthesiol-ogy 1995; 83: 968-75
12. Hughes MA, Glass PSA, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992; 76: 334-41
13. Dershwitz M, Hoke JF, Rosow CE, et al. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 1996; 84: 812-20
14. Hoke F, Shlugman D, Dershwitz M, et al. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal fail-ure compared with healthy volunteers. Anesthesiology 1997; 87: 533-41
15. Dahaba AA, Oettl K, von Klobucar F, et al. End-stage renal failure reduces central clearance and prolongs the elimination half life of remifentanil. Can J Anaesth 2002; 49: 369-74
16. Michelsen LG, Holford NHG, Lu W, et al. The pharmacokinetics of remifentanil in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Anesth Analg 2001; 93: 1100-5
17. Russell D, Royston D, Rees PH, et al. Effect of temperature and cardiopulmonary bypass on the pharmacokinetics of remifentanil. Br J Anaesth 1997; 79: 546-59
18. Ross AK, Davis PJ, deL Dear G, et al. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elec-tive surgery or diagnostic procedures. Anesth Analg 2001; 93: 1393-401
19. Davis PJ, Wilson AS, Siewers RD, et al. The effects of cardiopulmonary bypass on remifentanil kinetics in children undergoing atrial septal defect repair. Anesth Analg 1999; 89: 904-8
20. Wee LH, Moriarty A, Cranston A, et al. Remifentanil infusion for major abdominal surgery in small infants. Paediatr Anaesth 1999; 9: 415-8
21. Davis PJ, Finkel J, Orr R, et al. A randomized, double-blinded study of remifentanil versus fentanyl for tonsillectomy and adenoidectomy surgery in pediatric ambulatory surgical patients. Anesth Analg 2000; 90: 863-71
22. Chiaretti A, Pietrini D, Piastra M, et al. Safety and efficacy of remifentanil in craniosynostosis repair in children less than 1 year old. Pediatr Neurosurg 2000; 33: 83-8
23. Chambers N, Lopez T, Thomas J, et al. Remifentanil and the tunneling phase of paediatric ventriculoperitoneal shunt insertion: a double-blind, randomized, prospective study. Anaesthesia 2002; 57: 133-9
24. Friesen RH, Veit AS, Archibald DJ, et al. A comparison of remifentanil and fentanyl for fast track paediatric cardiac an-aesthesia. Paediatr Anaesth 2003; 13: 122-5
25. Dönmez A, Kizilkan A, Berksun H, et al. One center's experience with remifentanil infusions for pediatric cardiac catheterization. J Cardiothorac Vasc Anesth 2001; 15: 736-9
26. Litman RS. Conscious sedation with remifentanil during painful medical procedures. J Pain Symptom Manage 2000; 19: 468-71
27. Keidan I, Berkenstadt H, Sidi A, et al. Propofol/remifentanil versus propofol alone for bone marrow aspiration in paediatric haemato-oncological patients. Paediatr Anaesth 2001; 11: 297-301
28. German JW, Aneja R, Heard C, et al. Continuous remifentanil for pediatric neurosurgery patients. Pediatr Neurosurg 2000; 33: 227-9
29. Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. Anesthesiology 1997; 86: 10-23
30. Dershwitz M, Randel GI, Rosow CE, et al. Initial clinical experience with remifentanil, a new opioid metabolized by esterases. Anesth Analg 1995; 81: 619-23
31. Lang E, Kapila A, Shlugman D, et al. Reduction of isoflurane minimal alveolar concentration by remifentanil. Anesthesiology 1996; 85: 721-8
32. Westmoreland CL, Sebel PS, Gropper A. Fentanyl of alfentanil decreases the minimal alveolar anesthetic concentration of isoflurane in surgical patients. Anesth Analg 1994; 78: 23-8
33. Robinson DN, O'Brien K, Kumar R, et al. Tracheal intubation without neuromuscular blockade in children: a comparison of propofol combined either with alfentanil or remifentanil. Paediatr Anaesth 1998; 8: 467-71
34. Klemola UM, Hiller A. Tracheal intubation after induction of anesthesia in children with propofol: remifentanil or propofol-rocuronium. Can J Anesth 2000; 47 (9): 854-9
35. Davis PJ, Lerman J, Suresh S, et al. A randomized multicenter study of remifentanil compared with alfentanil, isoflurane, or propofol in anesthetized pediatric patients undergoing elective strabismus surgery. Anesth Analg 1997; 84: 982-9
36. Muñoz H, Cortínez L, Altermatt F, et al. Remifentanil requirements during sevoflurane administration to block somatic and cardiovascular responses to skin incision in children and adults. Anesthesiology 2002; 97: 1142-5
37. Prys-Roberts C, Lerman J, Murat I, et al. Comparison of remifentanil versus regional anaesthesia in children anaesthetized with isoflurane/nitrous oxide. Anaesthesia 2000; 55: 870-6
38. Davis PJ, Galinkin J, McGowan FX, et al. A randomized multicenter study of remifentanil compared with halothane in neonates and infants undergoing pyloromyotomy: I. Emergence and recovery profiles. Anesth Analg 2001; 93: 1380-6
39. Galinkin JL, Davis PJ, McGowan FX, et al. A randomized multicenter study of remifentanil compared with halothane in neonates and infants undergoing pyloromyotomy: II. Perioperative breathing patterns in neonates and infants with pyloric stenosis. Anesth Analg 2001; 93: 1387-92
40. Pinsker MC, Carroll NV. Quality of emergence from anesthesia and incidence of vomiting with remifentanil in a pediatric population. Anesth Analg 1999; 89: 71-4
41. Rüsch D, Happe W, Wulf H. Is TIVA with remifentanil/propofol superior to sevoflurane/N2O regarding PONV in children undergoing strabismus surgery? Der Anaesthesist 1999; 48: 80-8
42. Eltzschig HK, Schroeder TH, Eissler BJ, et al. The effect of remifentanil or fentanyl on postoperative vomiting and pain in children undergoing strabismus surgery. Anesth Analg 2002; 94: 1173-7
43. Haber GW, Litman RS. Generalized tonic-clonic activity after remifentanil administration. Anesth Analg 2001; 93: 1532-3
44. Strong WE, Matson M. Probable seizure after alfentanil. Anesth Analg 1989; 68: 692-3
45. Safwat AM, Daniel D. Grand mal seizure after fentanyl administration [letter]. Anesthesiology 1983; 59: 78
46. Brian JE, Seifen AB. Tonic-clonic activity after sufentanil. Anesth Analg 1987; 66: 481-3
47. Blair JM, Hill DA. Probable seizure after remifentanil in a 4-year-old boy. Anaesthesia 2000; 55: 489-518